Results 51 to 60 of about 25,524 (191)

The qualitative determination of oseltamivir phosphate in Tamiflu® capsule by cyclic voltammetry [PDF]

open access: yesHemijska Industrija, 2011
A gold electrode was applied in the voltammetric determination of oseltamivir phosphate standard in 0.05 M NaHCO3. Oseltamivir phosphate as a standard and as a component of Tamiflu® capsule exhibited the identical cyclic voltammogram.
Avramov-Ivić Milka L.   +3 more
doaj   +1 more source

Machine Learning and Structural Analysis for Generation‐Wise Selection of Perylene Diimide Dendrimers Based on Topological Compatibility With Drug Molecules

open access: yesChemistryOpen, Volume 15, Issue 11, November 2026.
Machine learning and graph‐theoretic descriptors are integrated to evaluate topology‐based compatibility between perylene diimide‐core dendrimer generations and antiviral, antioxidant, and imaging agents. Standardized structural similarity reveals generation‐dependent compatibility patterns, while Gaussian process regression uncovers key structure ...
Zainab Bibi   +5 more
wiley   +1 more source

Cost-effectiveness Scatter plot: Empiric treatment with oseltamivir vs. Post RIDT treatment with oseltamivir.

open access: yes, 2016
Cost-effectiveness Scatter plot: Empiric treatment with oseltamivir vs. Post RIDT treatment with oseltamivir.
Jiuhong Wu (2615215)   +3 more
core   +1 more source

A Novel Molecularly Imprinted Electrochemiluminescence Sensor Based on Mxene Quantum Dots for Selective Detection of Oseltamivir in Biological Samples

open access: yesMolecules
Oseltamivir is a drug that has been widely used to prevent and treat influenza A and B. In this work, an ultrasensitive, simple, and novel electrochemiluminescence (ECL) sensor combined with molecularly imprinted polymers (MIP-ECL) based on a graphene ...
Wei Guo   +7 more
doaj   +1 more source

THE CLINICAL AND LABORATORY EFFECTIVENESS OF OSELTAMIVIR FOR TREATMENT OF INFLUENZA IN HOSPITALIZED PATIENTS

open access: yesИнфекция и иммунитет, 2015
The goal of our study was to estimate the efficacy of antiviral drug Oseltamivir for influenza treatment. We assessed the effect of Oseltamivir on the immune status of the 75 patients.
L. V. Voloschcuk   +6 more
doaj   +1 more source

Detection of H275Y Mutation Conferring Oseltamivir Drug Resistance in Influenza A (H1N1) pdm09 Virus

open access: yesJournal of Pure and Applied Microbiology, 2021
In the treatment of influenza, Neuraminidase inhibitors (NAIs) (Oseltamivir and Zanamivir) play a major role. The emergence of variants of influenza A (H1N1) pdm09 virus resistant to Oseltamivir is a matter of great concern as it limits its usage ...
Khushbu Trivedi   +6 more
doaj   +1 more source

Study population in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy groups.

open access: yes, 2014
Study population in the azithromycin-oseltamivir combination therapy and oseltamivir monotherapy groups.
Masafumi Seki (535641)   +12 more
core   +1 more source

The stability of oseltamivir-NA complex and water-mediated H-bond.

open access: yes, 2022
The simulations were performed with oseltamivir-NA complex of NA tetramer. (a) The RMSD values of oseltamivir and (b) NA. (c) RMSD of the 16 individual oseltamivir-NA complex of the. (d) Column 1–16 is the average DON of individual oseltamivir-NA complex
Jiajing Ouyang (13171048)   +18 more
core   +1 more source

Matrix Metalloproteinase‐8 Deficiency Alters the Balance Between Viral Clearance and Immunopathology in H1N1 Infection

open access: yesThe FASEB Journal, Volume 40, Issue 19, 15 October 2026.
Mmp‐8 deficiency during H1N1 influenza infection enhances Type I interferon responses, necroptosis‐associated signaling, and adaptive immunity, leading to lower lung viral burden and improved survival, but also amplifies inflammatory lung injury. ABSTRACT Matrix metalloproteinase‐8 (MMP‐8) regulates inflammatory responses, but its contributions to the ...
Xiaoyun Wang   +4 more
wiley   +1 more source

Laboratory data for the azithromycin-oseltamivir combined therapy and oseltamivir monotherapy groups.

open access: yes, 2014
Laboratory data for the azithromycin-oseltamivir combined therapy and oseltamivir monotherapy groups.
Masafumi Seki (535641)   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy